| Glycolysis-mediated changes in acetyl-CoA and histone acetylation control the early differentiation of embryonic stem cells A Moussaieff, M Rouleau, D Kitsberg, M Cohen, G Levy, D Barasch, ... Cell metabolism 21 (3), 392-402, 2015 | 643 | 2015 |
| Association of checkpoint inhibitor–induced toxic effects with shared cancer and tissue antigens in non–small cell lung cancer F Berner, D Bomze, S Diem, OH Ali, M Fässler, S Ring, R Niederer, ... JAMA oncology 5 (7), 1043-1047, 2019 | 311 | 2019 |
| Long-term culture and expansion of primary human hepatocytes G Levy, D Bomze, S Heinz, SD Ramachandran, A Noerenberg, M Cohen, ... Nature biotechnology 33 (12), 1264-1271, 2015 | 159 | 2015 |
| Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors OH Ali, F Berner, D Bomze, M Fässler, S Diem, A Cozzio, M Jörger, ... European Journal of Cancer 107, 8-14, 2019 | 143 | 2019 |
| Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies OH Ali, D Bomze, L Risch, SD Brugger, M Paprotny, M Weber, S Thiel, ... Clinical Infectious Diseases, 2020 | 108* | 2020 |
| Association between immune-related adverse events during anti–PD-1 therapy and tumor mutational burden D Bomze, OH Ali, A Bate, L Flatz JAMA oncology 5 (11), 1633-1635, 2019 | 103 | 2019 |
| Topological small-world organization of the fibroblastic reticular cell network determines lymph node functionality M Novkovic, L Onder, J Cupovic, J Abe, D Bomze, V Cremasco, ... PLoS biology 14 (7), e1002515, 2016 | 103 | 2016 |
| Alternative NF‐κB signaling regulates mTEC differentiation from podoplanin‐expressing precursors in the cortico‐medullary junction L Onder, V Nindl, E Scandella, Q Chai, HW Cheng, S Caviezel‐Firner, ... European journal of immunology 45 (8), 2218-2231, 2015 | 88 | 2015 |
| BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors OH Ali, D Bomze, SS Ring, F Berner, M Fässler, S Diem, MT Abdou, ... Journal of the American Academy of Dermatology 82 (4), 854-861, 2020 | 75 | 2020 |
| Flavonoids as dietary regulators of nuclear receptor activity Y Avior, D Bomze, O Ramon, Y Nahmias Food & function 4 (6), 831-844, 2013 | 73 | 2013 |
| Adverse cardiovascular and pulmonary events associated with chimeric antigen receptor T-cell therapy A Goldman, E Maor, D Bomze, JE Liu, J Herrmann, J Fein, RM Steingart, ... Journal of the American College of Cardiology 78 (18), 1800-1813, 2021 | 65 | 2021 |
| Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients M Fässler, S Diem, J Mangana, O Hasan Ali, F Berner, D Bomze, S Ring, ... Journal for immunotherapy of cancer 7, 1-12, 2019 | 51 | 2019 |
| Nuclear receptors control pro-viral and antiviral metabolic responses to hepatitis C virus infection G Levy, N Habib, MA Guzzardi, D Kitsberg, D Bomze, E Ezra, BE Uygun, ... Nature chemical biology 12 (12), 1037-1045, 2016 | 49 | 2016 |
| Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma correspond to response and survival in nine patients treated with ipilimumab at the time of stage … S Diem, O Hasan Ali, CJ Ackermann, D Bomze, VH Koelzer, W Jochum, ... Cancer Immunology, Immunotherapy 67, 39-45, 2018 | 48 | 2018 |
| Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre‐COVID‐19 reports A Goldman, D Bomze, R Dankner, H Hod, T Meirson, B Boursi, E Maor British Journal of Clinical Pharmacology 87 (3), 1432-1442, 2021 | 47 | 2021 |
| Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors NG Nunez, F Berner, E Friebel, S Unger, N Wyss, JM Gomez, MT Purde, ... Med 4 (2), 113-129. e7, 2023 | 40 | 2023 |
| Comparison of 3 randomized clinical trials of frontline therapies for malignant pleural mesothelioma T Meirson, F Pentimalli, F Cerza, G Baglio, SG Gray, P Correale, ... JAMA Network Open 5 (3), e221490-e221490, 2022 | 34 | 2022 |
| Immunogenicity of a BNT162b2 vaccine booster in health-care workers E Saiag, H Goldshmidt, E Sprecher, R Ben-Ami, D Bomze The Lancet Microbe 2 (12), e650, 2021 | 32 | 2021 |
| Ocular adverse events induced by immune checkpoint inhibitors: a comprehensive pharmacovigilance analysis D Bomze, T Meirson, O Hasan Ali, A Goldman, L Flatz, Z Habot-Wilner Ocular immunology and inflammation 30 (1), 191-197, 2022 | 31 | 2022 |
| Structural basis of SARS-CoV-2 spike protein induced by ACE2 T Meirson, D Bomze, G Markel Bioinformatics 37 (7), 929-936, 2021 | 29 | 2021 |
Lukas FlatzUniversity of Tübingen (Medical Faculty)Verified email at med.uni-tuebingen.de
